Search

Displaying results 7791 - 7800 of 10000 in total
  1. Drug

    BMS-777607

    go.drugbank.com/drugs/DB12064
    Investigational

    BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.

  2. Drug

    OBP-801

    go.drugbank.com/drugs/DB12279
    Investigational

    OBP-801 has been used in trials studying the treatment of Solid Tumor.

  3. Drug

    Tipelukast

    go.drugbank.com/drugs/DB12435
    Investigational

    Tipelukast is under investigation for the treatment of IPF and Idiopathic pulmonary fibrosis.

  4. Drug

    Pf-04531083

    go.drugbank.com/drugs/DB12468
    Investigational

    Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.

  5. Drug

    Verucerfont

    go.drugbank.com/drugs/DB12512
    Investigational

    Verucerfont has been used in trials studying the treatment of Congenital Adrenal Hyperplasia.

  6. Drug

    Tedatioxetine

    go.drugbank.com/drugs/DB12641
    Investigational

    Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.

  7. Drug

    Olumacostat glasaretil

    go.drugbank.com/drugs/DB12642
    Investigational

    Olumacostat glasaretil has been used in trials studying the treatment of Acne Vulgaris.

  8. Drug

    Ozagrel

    go.drugbank.com/drugs/DB12017
    Investigational

    Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.

  9. Drug

    Rineterkib

    go.drugbank.com/drugs/DB17560
    Investigational

    Rineterkib is an inhibitor of extracellular signal-regulated kinase (ERK) being investigated in NCT04097821 (A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety and Efficacy of Novel

  10. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications.